ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CABANewsfile Corp • 03/10/22
Shareholder Action Alert: The Schall Law Firm Encourages Investors In Cabaletta Bio, Inc. With Losses Of $100,000 To Contact The FirmNewsfile Corp • 03/10/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Cabaletta Bio (CABA) Investors to Filing of Securities Class Action, Encourages Investors with Losses to Contact Firm's AttorneysNewsfile Corp • 03/10/22
CABA INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CABANewsfile Corp • 03/09/22
ROSEN, A LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CABANewsfile Corp • 03/08/22
NOTICE: Cabaletta Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – CABABusiness Wire • 03/08/22
DEADLINE: Cabaletta Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CABAPRNewsWire • 03/05/22
ROSEN, A TOP RANKED FIRM, Encourages Cabaletta Bio, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - CABAPRNewsWire • 03/05/22
CABA INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Cabaletta Bio (CABA) Investors with Significant Losses to Contact Firm's Attorneys, Securities Class Action FiledPRNewsWire • 03/03/22
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cabaletta Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 29, 2022 - CABANewsfile Corp • 03/02/22
CABA SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Class Action Against Cabaletta Bio, Inc. (CABA)Business Wire • 03/02/22
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 03/02/22
Bronstein, Gewirtz & Grossman, LLC Notifies Cabaletta Bio, Inc. (CABA) Investors of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 03/02/22
CABALETTA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cabaletta Bio, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 03/02/22
SHAREHOLDER ALERT: Robbins LLP Informs Investors of Class Action Against Cabaletta Bio, Inc. (CABA)Business Wire • 03/01/22
ALERT: Cabaletta Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CABAPRNewsWire • 03/01/22
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CABABusiness Wire • 03/01/22
Pomerantz Law Firm Announces the Filing of a Class Action Against Cabaletta Bio, Inc., and Certain Officers - CABAPRNewsWire • 03/01/22
Cabaletta Bio to Participate in the Cowen Virtual 42nd Annual Health Care ConferenceGlobeNewsWire • 02/28/22
Cabaletta Bio Strengthens Executive Leadership Team with Promotions of Gwendolyn Binder, Ph.D. to President of Science and Technology and Arun Das, M.D.GlobeNewsWire • 01/11/22
Cabaletta Bio to Present at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/10/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cabaletta Bio, Inc. - CABAPRNewsWire • 01/06/22
Oxford Biomedica inks licence and supply deal for LentiVector with Cabaletta BioProactive Investors • 01/05/22
Down 63.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Cabaletta Bio, Inc. (CABA)Zacks Investment Research • 01/04/22
Cabaletta Bio's Cell Therapy Fails To Show Activity At Low Doses In Skin Blistering DisorderBenzinga • 12/14/21
